Cancer Treatment News and Research

RSS

Study links patient characteristics with the likelihood of bypassing the nearest surgical center for breast cancer treatment

Researchers investigated hospital quality and patient factors associated with treatment location for breast cancer surgery.

10 Jan 2024

Dresden makes waves in cancer treatment with pioneering MRI-guided proton therapy

On January 9th, 2024, a scientific prototype for MRI-guided proton therapy was inaugurated in Dresden.

9 Jan 2024

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

Amino acid nanoparticles show promise for cancer treatment

Amino acids, such as tyrosine and tryptophan, are the fundamental building blocks that make up proteins.

8 Jan 2024

Study examines patient choice and hospital selection for breast-conserving surgery and mastectomy

Including patients as partners for making decisions about their medical treatments is an important aspect of patient-centered care.

8 Jan 2024

Growing tiny tumors in the lab for personalized lung cancer treatment

Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year.

8 Jan 2024

Researchers identify mechanism that causes gastrointestinal problems with cancer immunotherapy

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment.

5 Jan 2024

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Scientists have solved a cellular murder mystery nearly 25 years after the case went cold. Following a trail of evidence from fruit flies to mice to humans revealed that cannibalistic cells likely cause a rare human immunodeficiency.

5 Jan 2024

Discovery on housekeeping genetic elements reveals a novel avenue in cancer therapy

Technological advancements have enabled scientists to comprehensively explore genetic control elements, unraveling the complexities of gene activation mechanisms in our genetic code.

5 Jan 2024

Metabolically armored CAR-T cells demonstrate lasting efficacy against solid tumors

At EPFL's School of Engineering, Professor Li Tang's Laboratory of Biomaterials for Immunoengineering has made significant strides in cancer treatment research.

4 Jan 2024

"NK cell-engaging nanodrones" can selectively target and kill cancer cells

A groundbreaking study led by Professor Sebyung Kang and Professor Sung Ho Park in the Department of Biological Sciences at UNIST has unveiled a remarkable breakthrough in cancer treatment.

29 Dec 2023

Johns Hopkins researchers find minimal regret after gender affirming surgery

In a Viewpoint article published Dec. 27, 2023, in JAMA Surgery, three Johns Hopkins researchers urge the medical community to dismiss a widely held, but scientifically unsupported belief that many people who are transgender and gender diverse (TGD), and undergo gender affirming surgery (GAS), later regret their decision to undergo such procedures.

28 Dec 2023

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

The Radiopharmaceutical Therapy and Dosimetry Lab at Johns Hopkins Medicine, headed by George Sgouros, Ph.D., has been awarded a $15 million grant, to be dispersed over the next five years, from the National Cancer Institute at the National Institutes of Health.

28 Dec 2023

$Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL$

Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL

Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat) diffuse large B-cell lymphoma (r/r DLBCL), according to a study published today in Blood Advances.

28 Dec 2023

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.

27 Dec 2023

New drug screening system helps uncover promising target for pancreatic cancer treatments

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell Medicine.

26 Dec 2023

Groundbreaking treatment tool being developed for male breast cancer diagnosis

Doctors diagnosed Christopher Gregg, Ph.D., member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah (the U) and neuroscientist and professor of neurobiology and human genetics at the U, with stage 4 metastatic breast cancer in 2018.

21 Dec 2023

Cancer Treatment News and Research

Study links patient characteristics with the likelihood of bypassing the nearest surgical center for breast cancer treatment

Dresden makes waves in cancer treatment with pioneering MRI-guided proton therapy

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Amino acid nanoparticles show promise for cancer treatment

Study examines patient choice and hospital selection for breast-conserving surgery and mastectomy

Growing tiny tumors in the lab for personalized lung cancer treatment

Researchers identify mechanism that causes gastrointestinal problems with cancer immunotherapy

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Discovery on housekeeping genetic elements reveals a novel avenue in cancer therapy

Metabolically armored CAR-T cells demonstrate lasting efficacy against solid tumors

"NK cell-engaging nanodrones" can selectively target and kill cancer cells

Johns Hopkins researchers find minimal regret after gender affirming surgery

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

New drug screening system helps uncover promising target for pancreatic cancer treatments

Groundbreaking treatment tool being developed for male breast cancer diagnosis

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

New $3.2 million grant fuels collaborative fight against cancers

Poop-based test predicts postoperative infections in liver transplant patients

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News